Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 3, 2019
Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy
Evan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
Viruses
|
November 24, 2022
Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders
Heiner Wedemeyer, Vito Di Marco, Montserrat Garcia-Retortillo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 14, 2020
Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject Drugs
Evan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
Blood
|
May 25, 2016
Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience
Beatriz Morillo-Gutierrez, Rita Beier, Kanchan Rao, et al.
BMC Public Health
|
January 10, 2025
A prospective multi-site study to evaluate the performance and usability of an oral fluid-based HIV self-test in Canada
Richard A Galli, Darshanand Maraj, Kristin McBain, et al.
British Journal of Cancer
|
June 1, 2022
Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions
Nicola C Venn, Libby Huang, Lenka Hovorková, et al.
Transplantation and Cellular Therapy
|
March 19, 2023
Incidence of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease and Treatment with Defibrotide in Allogeneic Transplantation: A Multicenter Australasian Registry Study
John Coutsouvelis, Carl M Kirkpatrick, Michael Dooley, et al.
The International Journal on Drug Policy
|
June 24, 2025
Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study
Joshua Ang, Behzad Hajarizadeh, Shane Tillakeratne, et al.
The International Journal on Drug Policy
|
November 2, 2018
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy
Jason Grebely, Brian Conway, Evan B Cunningham, et al.
The International Journal on Drug Policy
|
October 24, 2018
Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study
Evan B Cunningham, Janaki Amin, Jordan J Feld, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 3, 2019
Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy
Evan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
Viruses
|
November 24, 2022
Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders
Heiner Wedemeyer, Vito Di Marco, Montserrat Garcia-Retortillo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 14, 2020
Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject Drugs
Evan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
Blood
|
May 25, 2016
Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience
Beatriz Morillo-Gutierrez, Rita Beier, Kanchan Rao, et al.
BMC Public Health
|
January 10, 2025
A prospective multi-site study to evaluate the performance and usability of an oral fluid-based HIV self-test in Canada
Richard A Galli, Darshanand Maraj, Kristin McBain, et al.
British Journal of Cancer
|
June 1, 2022
Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions
Nicola C Venn, Libby Huang, Lenka Hovorková, et al.
Transplantation and Cellular Therapy
|
March 19, 2023
Incidence of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease and Treatment with Defibrotide in Allogeneic Transplantation: A Multicenter Australasian Registry Study
John Coutsouvelis, Carl M Kirkpatrick, Michael Dooley, et al.
The International Journal on Drug Policy
|
June 24, 2025
Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study
Joshua Ang, Behzad Hajarizadeh, Shane Tillakeratne, et al.
The International Journal on Drug Policy
|
November 2, 2018
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy
Jason Grebely, Brian Conway, Evan B Cunningham, et al.
The International Journal on Drug Policy
|
October 24, 2018
Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study
Evan B Cunningham, Janaki Amin, Jordan J Feld, et al.
Page
of 8